Physician profile
Bryant Brown
NPI 1629038963
$2,110.77
in general payments reported to CMS, 2019-2025
29 companies · $68.49 in 2025
The $68.49 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $458 · 2021: $521 · 2022: $334 · 2023: $237 · 2024: $61.11 · 2025: $68.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $416.52 | 2019-2023 | Liletta |
| Intuitive Surgical, INC. | $231.03 | 2019-2022 | |
| Astellas Pharma US INC | $194.84 | 2019-2025 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $144.39 | 2019-2021 | |
| Evofem Biosciences, INC. | $135.67 | 2020-2021 | |
| Organon LLC | $101.61 | 2021-2025 | Nexplanon |
| Ascend Therapeutics US, LLC | $90.39 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $87.41 | 2019-2021 | |
| Coloplast Corp | $68.50 | 2022 | |
| Merck Sharp & Dohme LLC | $64.53 | 2020-2023 | Gardasil 9 |
| Myovant Sciences INC. | $62.94 | 2021-2022 | |
| Hologic Sales and Service, LLC | $57.74 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $54.93 | 2021-2023 | |
| Lupin INC. | $49.26 | 2019-2020 | |
| Baxter Healthcare | $38.63 | 2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $38.06 | 2019-2020 | |
| Becton, Dickinson and Company | $35.47 | 2021 | |
| Roche Diagnostics Corporation | $28.27 | 2019-2021 | |
| Avion Pharmaceuticals | $26.65 | 2021-2022 | |
| Exeltis, USA INC. | $24.16 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $23.99 | 2023 | Bd Onclarity |
| Medicem INC. | $22.98 | 2021 | |
| Ethicon US, LLC | $18.51 | 2025 | Vistaseal |
| Pfizer INC. | $17.72 | 2022 | |
| Scynexis, INC. | $17.25 | 2022 | |
| Meditrina | $16.37 | 2025 | |
| Urovant Sciences INC | $16.07 | 2022 | |
| Axonics, INC. | $15.11 | 2022 | |
| Microline Surgical INC | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryant Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.